PharmaLogic Holdings Corp.

PharmaLogic is a world-class contract development and manufacturing organization specializing in novel diagnostic imaging and therapeutic radiopharmaceuticals for the treatment of cancers and other malignancies. In addition to an established and reliable network of radiopharmacies, PharmaLogic has decades of expertise in drug development from discovery, through manufacturing and commercialization. With over 40 radiopharmacies and 9 cyclotrons throughout the United States and Canada, PharmaLogic is the second-largest CDMO in North America. The Company seeks to Take The Lead in the advancement of radiopharmaceutical technology for the benefit of patients worldwide. For more information, visit: www.radiopharmacy.com